Drug-like antibodies with low immunogenicity in human panels designed with Latent-X2

Latent Labs Team, Henry Kenlay, Daniella Pretorius +15

Drug discovery has long sought computational systems capable of designing drug-like molecules directly: developable and non-immunogenic from the start. Here we introduce Latent-X2,…